Company profilePharmaceutical#142 of 1,318 in Pakistan✓ No DRAP alerts

English Pharmaceutical Indsutries

Pharmaceutical company · 118 brands · 99 molecules

Ranked #8 of 39 companies in Beta-Lactam Antibacterials, Penicillins

118 registered products 51 pharmaceutical brands 99 distinct molecules 0 DRAP alerts

Company overview

118
registered products
51
pharmaceutical brands
99
distinct molecules
12
therapeutic classes
0
DRAP alerts

English Pharmaceutical Indsutries is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 118 product registrations across 99 distinct molecules. It is the 142nd largest registrant in Pakistan by product count, and ranks 8th of 39 in Beta-Lactam Antibacterials, Penicillins. Its portfolio is concentrated in Beta-Lactam Antibacterials, Penicillins and Other Analgesics And Antipyretics. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by English

3 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

2
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20262

Top molecules by brand count

Amoxicillin7 brands
Paracetamol5 brands
Levofloxacin5 brands
Amikacin4 brands
Omeprazole3 brands
Artesunate3 brands
Cefixime3 brands
Piperacillin3 brands

Therapeutic classes

Beta-Lactam Antibacterials, Penicillins · 3Other Analgesics And Antipyretics · 2Antiemetics & Antinauseants · 2Anti-Infectives · 1Antihaemorrhagic · 1Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 1Antiinflammatory And Antirheumatic Products · 1Quinolone Antibacterials · 1Antimalarials · 1Antianemic, Iron Preparations · 1Antimycotics Systemic Use · 1Antivirals For Systemic Use · 1

Conditions treated

General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official135 products · Rs 6.87 – Rs 10,139.53
DVAGO4 products · Rs 115.9 – Rs 1,421.2
Servaid1 products · Rs 912.7 – Rs 912.7
Median across source: Rs 415.05

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.27 shared molecules
EPHARM LABORATORIES25 shared molecules
MEDISAVE PHARMACEUTICALS25 shared molecules
NEUTRO PHARMA (PVT) LTD.25 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NABIQASIM INDUSTRIES (PVT) LTD. holds 193 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
Horizon Pharmaceuticals (Pvt) Limited holds 135 molecules not in this portfolio
000 I.UAcyclovirAlbendazoleAmlodipineAmoxicillinAmoxycillin Base
BOSCH PHARMACEUTICALS (PVT) LTD. holds 154 molecules not in this portfolio
AmikacinAmlodipineAmoxicillinAmoxicillin SodiumAmoxicillin …50Mg Clavulanic Acid 12.5 MgAmoxycillin

Get the full profile for English

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.